MBAM
CSBR icon

Mink Brook Asset Management’s Champions Oncology CSBR Stock Holding History

Mink Brook Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$686K Hold
111,338
– – 0.3% 38
2026
Q1 		$640K Buy
111,338
+31,033
+39% +$197K 0.36% 39
2025
Q4 		$555K Buy
+80,305
New +$535K 0.35% 30

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Mink Brook Asset Management's CSBR Position: Q2 2026 in Review

Mink Brook Asset Management held its Champions Oncology (CSBR) position steady in Q2 2026 at 111,338 shares worth $686K. The position accounts for 0.3% of the portfolio, ranked #38.

Mink Brook Asset Management first reported a position in CSBR in Q4 2025 and has held it in 3 quarters since. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Mink Brook Asset Management held 111,338 shares of Champions Oncology worth $686K as of Q2 2026.
  • Mink Brook Asset Management left its Champions Oncology share count unchanged in Q2 2026.
  • Champions Oncology made up 0.3% of Mink Brook Asset Management's portfolio in Q2 2026, its #38 holding.
  • Mink Brook Asset Management first reported a position in Champions Oncology in Q4 2025 and has held it in 3 quarters since.
  • 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Mink Brook Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.